166 related articles for article (PubMed ID: 27844417)
1. Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation.
Yadav NK; Nanda S; Sharma G; Katare OP
AAPS PharmSciTech; 2017 Jul; 18(5):1863-1880. PubMed ID: 27844417
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid gel-core liposomes (hyaluosomes) enhance skin permeation of ketoprofen.
Kawar D; Abdelkader H
Pharm Dev Technol; 2019 Oct; 24(8):947-953. PubMed ID: 30676142
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
5. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
6. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
Garg BJ; Garg NK; Beg S; Singh B; Katare OP
J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
[TBL] [Abstract][Full Text] [Related]
7. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible phospholipid-based nanovesicular drug delivery system of ketoprofen: Systematic development, optimization, and preclinical evaluation.
Bimbrawh S; Chopra S; Ansari MJ; Alrobaian M; Almalki WH; Alharbi KS; Alenezi SK; Kaur R; Beg S; Bhatia A
Biotechnol Appl Biochem; 2023 Feb; 70(1):51-67. PubMed ID: 35262954
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
Aboelwafa AA; El-Setouhy DA; Elmeshad AN
AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
[TBL] [Abstract][Full Text] [Related]
10. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.
Bonina FP; Puglia C; Barbuzzi T; de Caprariis P; Palagiano F; Rimoli MG; Saija A
Eur J Pharm Sci; 2001 Sep; 14(2):123-34. PubMed ID: 11500258
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.
Ibrahim MM; Sammour OA; Hammad MA; Megrab NA
AAPS PharmSciTech; 2008; 9(3):782-90. PubMed ID: 18587650
[TBL] [Abstract][Full Text] [Related]
13. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
14. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis.
Srivastava M; Kohli K; Ali M
Drug Deliv; 2016; 23(1):154-66. PubMed ID: 24786482
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
16. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
Ramkanth S; Chetty CM; Sudhakar Y
Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
[TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
[TBL] [Abstract][Full Text] [Related]
19. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
20. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.
Abdelbary GA; Aburahma MH
J Liposome Res; 2015; 25(2):107-21. PubMed ID: 25058447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
